Hammes H P, Brownlee M, Lin J, Schleicher E, Bretzel R G
3rd Medical Department, Centre of Internal Medicine, Justus-Liebig-University, Giessen, Germany.
Diabetologia. 1999 May;42(5):603-7. doi: 10.1007/s001250051201.
AIMS/HYPOTHESIS: We investigated whether either the amount of diabetes-induced intracellular oxidative stress or the concentration of hyperglycaemia-induced advanced glycation endproducts is associated with the risk of diabetic retinopathy.
We measured concentrations of the glycoxidation product Nepsilon-(carboxymethyl)lysine and two non-oxidation-dependent advanced glycation end-products (methylglyoxal-derived and 3-deoxyglucosone-derived) in CD45RA+ T-cells from 21 Type I (insulin-dependent) diabetic patients with and without diabetic retinopathy and from age-matched nondiabetic control subjects.
Intracellular concentrations of both oxidation-dependent Nepsilon-(carboxymethyl)lysine and oxidation-independent advanced glycation endproducts were increased in memory T-cells from diabetic patients. Nepsilon-(carboxymethyl)lysine: diabetic median-24176 arbitrary units/mg protein (95% confidence interval 18690-34099 arbitrary units/mg protein); nondiabetic-9088 arbitrary units/mg protein (confidence interval 6994-10696 arbitrary units/mg protein; p < 0.0001). Methylglyoxal-derived advanced glycation end products: diabetic-5430 arbitrary units/ mg protein (confidence interval 3458-13610); nondiabetic-271 arbitrary units/mg protein (confidence interval 61-760 arbitrary units/mg protein; p< 0.0001). 3-Deoxyglucosone-derived advanced glycation end products: diabetic-8070 arbitrary units/mg protein (confidence interval 7049-16551 arbitrary units/mg protein); nondiabetic-1479 arbitrary units/ mg protein (confidence interval 1169-3170; p< 0.0001). Only Nepsilon-(carboxymethyl)lysine concentrations, however, inversely correlated with the duration of retinopathy-free diabetes (r = -0.51; p < 0.02). Diabetes-dependent Nepsilon-(carboxymethyl)lysine accumulation did not correlate with age, diabetes duration, or averaged glycohaemoglobin concentrations. In vitro experiments wih menadione and lymphocytes confirmed that Nepsilon-(carboxymethyl)lysine concentrations reflect intracellular oxidative stress.
CONCLUSION/INTERPRETATION: Monitoring intracellular concentrations of increased oxidative stress in long-lived CD45RA+ lymphocytes by markers such as Nepsilon-(carboxymethyl)lysine possibly identifies a subgroup of patients at high risk for microvascular complications.
目的/假设:我们研究了糖尿病诱导的细胞内氧化应激量或高血糖诱导的晚期糖基化终产物浓度是否与糖尿病视网膜病变风险相关。
我们测量了21名1型(胰岛素依赖型)糖尿病患者(有或无糖尿病视网膜病变)以及年龄匹配的非糖尿病对照受试者的CD45RA + T细胞中糖氧化产物Nε-(羧甲基)赖氨酸和两种非氧化依赖性晚期糖基化终产物(甲基乙二醛衍生和3-脱氧葡萄糖醛酸衍生)的浓度。
糖尿病患者记忆T细胞中氧化依赖性Nε-(羧甲基)赖氨酸和非氧化依赖性晚期糖基化终产物的细胞内浓度均升高。Nε-(羧甲基)赖氨酸:糖尿病患者中位数为24176任意单位/毫克蛋白质(95%置信区间为18690 - 34099任意单位/毫克蛋白质);非糖尿病患者为9088任意单位/毫克蛋白质(置信区间为6994 - 10696任意单位/毫克蛋白质;p < 0.0001)。甲基乙二醛衍生的晚期糖基化终产物:糖尿病患者为5430任意单位/毫克蛋白质(置信区间为3458 - 13610);非糖尿病患者为271任意单位/毫克蛋白质(置信区间为61 - 760任意单位/毫克蛋白质;p < 0.0001)。3-脱氧葡萄糖醛酸衍生的晚期糖基化终产物:糖尿病患者为8070任意单位/毫克蛋白质(置信区间为7049 - 16551任意单位/毫克蛋白质);非糖尿病患者为1479任意单位/毫克蛋白质(置信区间为1169 - 3170;p < 0.0001)。然而,只有Nε-(羧甲基)赖氨酸浓度与无视网膜病变糖尿病的病程呈负相关(r = -0.51;p < 0.02)。糖尿病相关的Nε-(羧甲基)赖氨酸积累与年龄、糖尿病病程或平均糖化血红蛋白浓度无关。用甲萘醌和淋巴细胞进行的体外实验证实,Nε-(羧甲基)赖氨酸浓度反映细胞内氧化应激。
结论/解读:通过Nε-(羧甲基)赖氨酸等标志物监测长寿CD45RA +淋巴细胞中细胞内氧化应激增加的浓度,可能识别出微血管并发症高风险患者亚组。